-
1.发明授权Peptide analogues comprising at least one type of aminoacylaza-$g(b)3 and the use thereof, in particular for therapy 有权包含至少一种类型的氨基酰肼基（b）的肽类似物及其用途，特别是用于治疗公开(公告)号：US09017673B2
公开(公告)日：2015-04-28
申请号：US10560163
申请日：2004-06-11
CPC分类号： A61K39/395 , A61K38/00 , C07C281/02 , C07C323/48 , C07K14/47 , Y02A50/385 , Y02P20/55
摘要： The object of the present invention is analogues of peptides or parent proteins, these peptide analogues, comprising at least one aza-β3 aminoacyl residue, and also their uses in pharmaceutical compositions or for the diagnosis of pathologies wherein the aforesaid peptides or parent proteins are involved.
摘要翻译： 本发明的目的是肽或亲本蛋白质的类似物，这些肽类似物包含至少一个氮杂 - 3'-酰基残基，以及它们在药物组合物中的用途或用于诊断病症，其中上述肽或亲本蛋白 涉及。
-
2.发明申请Peptide analogues comprising at least one type of aminoacylaza-$g(b)3 and the use thereof, in particular for therapy 有权包含至少一种类型的氨基酰肼基（b）的肽类似物及其用途，特别是用于治疗公开(公告)号：US20110044974A1
公开(公告)日：2011-02-24
申请号：US10560163
申请日：2004-06-11
IPC分类号： A61K39/395 , C07K7/08 , C07K16/00 , C07K16/42 , G01N33/566 , C07C227/14 , C07C229/26 , A61K39/00 , A61K38/10 , A61P31/04 , A61P31/12 , A61P3/10 , A61P25/28 , A61P17/00 , A61P29/00 , A61P31/18 , A61P31/22 , A61P31/14 , A61P19/04 , A61P31/16 , A61P1/16 , A61P17/06 , A61P7/06 , A61P25/00
CPC分类号： A61K39/395 , A61K38/00 , C07C281/02 , C07C323/48 , C07K14/47 , Y02A50/385 , Y02P20/55
摘要： The object of the present invention is analogues of peptides or parent proteins, these peptide analogues, comprising at least one aza-β3 aminoacyl residue, and also their uses in pharmaceutical compositions or for the diagnosis of pathologies wherein the aforesaid peptides or parent proteins are involved.
摘要翻译： 本发明的目的是肽或亲本蛋白质的类似物，这些肽类似物包含至少一个氮杂 - 3'-酰基残基，以及它们在药物组合物中的用途或用于诊断病症，其中上述肽或亲本蛋白 涉及。
-
公开(公告)号：US08519188B2
公开(公告)日：2013-08-27
申请号：US12997764
申请日：2009-06-15
申请人： Denis Carniato , Karine Jaillardon , Olivier Busnel , Mathieu Gutmann , Jean-Francois Briand , Benoit Deprez , Dominique Thomas , Cécile Bougeret
发明人： Denis Carniato , Karine Jaillardon , Olivier Busnel , Mathieu Gutmann , Jean-Francois Briand , Benoit Deprez , Dominique Thomas , Cécile Bougeret
IPC分类号： C07C233/05 , A61K31/16 , A61K31/381 , A61K31/433 , C07D333/24 , C07D417/12
CPC分类号： C07D333/24 , C07C237/22 , C07C237/24 , C07C255/60 , C07C323/63 , C07C2601/14 , C07D207/09 , C07D211/66 , C07D213/56 , C07D215/38 , C07D231/56 , C07D233/64 , C07D237/20 , C07D257/04 , C07D285/06 , C07D295/092 , C07D295/155 , C07D307/14 , C07D307/52 , C07D317/58 , C07D317/60 , C07D319/18 , C07D409/12 , C07D417/12
摘要： The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them.
摘要翻译： 本发明涉及通式（I）的化合物及其药学上可接受的盐，它们以各种比例的异构体或异构体混合物，特别是涉及对映体混合物，特别是外消旋混合物。 本发明还涉及这些化合物作为药物，特别是用于治疗癌症以及含有它们的组合物的用途。
-
公开(公告)号：US20110104162A1
公开(公告)日：2011-05-05
申请号：US12997764
申请日：2009-06-15
申请人： Denis Carniato , Karine Jaillardon , Olivier Busnel , Mathieu Gutmann , Jean-Francois Briand , Benoit Deprez , Dominique Thomas , Cécile Bougeret
发明人： Denis Carniato , Karine Jaillardon , Olivier Busnel , Mathieu Gutmann , Jean-Francois Briand , Benoit Deprez , Dominique Thomas , Cécile Bougeret
IPC分类号： A61K31/381 , C07D333/24 , C07C237/24 , C07C237/20 , C07D417/12 , C07D409/12 , C07D413/12 , C07D317/60 , C07D319/18 , C07C255/44 , C07F5/02 , C07D207/06 , C07C237/18 , C07C255/60 , C07D211/58 , C07D213/56 , C07D295/155 , C07D307/54 , C07D215/38 , C07D307/16 , C07D409/06 , A61K31/282 , A61K33/24 , A61K31/433 , A61K31/506 , A61K31/5377 , A61K31/69 , A61K31/166 , A61K39/395 , A61P35/00 , A61K31/495 , A61K31/496 , A61K31/445 , A61K31/4406
CPC分类号： C07D333/24 , C07C237/22 , C07C237/24 , C07C255/60 , C07C323/63 , C07C2601/14 , C07D207/09 , C07D211/66 , C07D213/56 , C07D215/38 , C07D231/56 , C07D233/64 , C07D237/20 , C07D257/04 , C07D285/06 , C07D295/092 , C07D295/155 , C07D307/14 , C07D307/52 , C07D317/58 , C07D317/60 , C07D319/18 , C07D409/12 , C07D417/12
摘要： The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them.
摘要翻译： 本发明涉及通式（I）的化合物及其药学上可接受的盐，它们以各种比例的异构体或异构体混合物，特别是涉及对映体混合物，特别是外消旋混合物。 本发明还涉及这些化合物作为药物，特别是用于治疗癌症以及含有它们的组合物的用途。
-
-
-
搜索结果
4 条记录 (耗时 0.018 秒)
